Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Glaucoma, Angle Recession : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Multimedia
References

Related Articles
Glaucoma, Angle Closure, Acute

Glaucoma, Angle Closure, Chronic

Glaucoma, Lens-Particle

Glaucoma, Neovascular

Glaucoma, Phacolytic

Glaucoma, Pigmentary

Glaucoma, Primary Open Angle

Glaucoma, Pseudoexfoliation

Glaucoma, Unilateral

Glaucoma, Uveitic

Melanoma, Ciliary Body

Melanoma, Iris




Patient Education
Glaucoma Center

Angle Recession Glaucoma Overview

Angle Recession Glaucoma Causes

Angle Recession Glaucoma Symptoms

Angle Recession Glaucoma Treatment

Understanding Glaucoma Medications

Glaucoma FAQs




Author: Brian R Sullivan, MD, Associate Professor, Department of Ophthalmology, University of Texas Southwestern Medical Center

Brian R Sullivan is a member of the following medical societies: American Academy of Ophthalmology and American Society of Cataract and Refractive Surgery

Editors: Andrew I Rabinowitz, MD, Consulting Staff, Department of Ophthalmology, Barnet Dulaney Perkins Eye Center; Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles; Martin B Wax, MD, Clinical Professor, Department of Ophthalmology, University of Texas Southwestern Medical School; Vice President, Ophthalmology Research and Development, Head, Ophthalmology Discovery Research, Alcon Labs, Inc; Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri; Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Author and Editor Disclosure

Synonyms and related keywords: angle-recession glaucoma, angle recession glaucoma, posttraumatic angle recession glaucoma, contusion angle recession glaucoma, contusion angle deformity, traumatic glaucoma, traumatic angle recession glaucoma, intraocular pressure, IOP, optic neuropathy, open-angle glaucoma

Background

Traumatic glaucoma refers to a heterogeneous group of posttraumatic ocular disorders with different underlying mechanisms that lead to the common pathway of abnormal elevation of intraocular pressure (IOP) and increased risk of optic neuropathy.

Angle-recession glaucoma is classified as a type of traumatic, secondary open-angle glaucoma. This condition may be underdiagnosed because onset is often delayed and because a history of eye injury may be distant or forgotten.

The finding of angle recession, with or without glaucoma, is a common sequela of blunt ocular trauma and one characterized by a variable degree of cleavage between the circular and the longitudinal fibers of the ciliary muscle.

Treacher Collins based the first report of this postcontusional angle deformity on gross examination of enucleated eyes in 1892.

In 1944, D'Ombrain observed the association of ocular trauma and chronic unilateral glaucoma, suggesting abnormalities in the region of the trabecular meshwork as the underlying cause. This theory was substantiated by the classic histologic findings of angle recession published in 1962 by Wolf and Zimmerman, and numerous authors have confirmed the relationship of glaucoma with traumatic angle abnormalities.

Although a relatively uncommon phenomenon, angle-recession glaucoma may be overlooked in the management of nonpenetrating eye trauma. Long-term follow-up care of patients with recognized contusional angle abnormality is warranted due to the risk of delayed, asymptomatic onset.

Pathophysiology

The mechanism of glaucoma associated with angle recession appears to involve 5 processes.

First, blunt force delivered to the globe initiates an anterior to posterior axial compression with equatorial expansion. Sudden indentation of the cornea may be a key factor in angle trauma, creating a hydrodynamic effect by which aqueous is rapidly forced laterally, deepening the peripheral anterior chamber and increasing the diameter of the corneoscleral limbal ring.

Second, this transient anatomic deformity results in a shearing force applied to the angle structures, causing disruption at the weakest points if the force applied exceeds the elasticity of the tissues.

Third, although multiple anterior segment structures can be damaged by the above mechanism, a common site of avulsion involves the ciliary muscle. In angle recession, the ciliary body is torn in a manner such that the longitudinal muscle remains attached to its insertion at the scleral spur, while the circular muscle, with the pars plicata and the iris root, is displaced posteriorly. During this process, shearing of the anastomotic branches of the anterior ciliary arteries can occur, resulting in a hyphema. The anterior chamber typically becomes abnormally deep in the meridians of recessed angle due to posterior deviation of the relaxed iris-lens diaphragm. Subsequently, a fissure representing the separation of the longitudinal and circular fibers may be visible by gonioscopy or by histologic examination.

Fourth, in some cases, angle recession progresses to glaucoma. The contusional deformity, when extensive, may result in trabecular dysfunction, which may lead to early or delayed loss of outflow facility and elevation of IOP. The mechanism is not well understood, but evidence suggests an increased incidence of primary open-angle glaucoma (POAG) in the other eye of affected patients. One theory suggests that patients with angle-recession glaucoma have an independent, perhaps genetic, predisposition to chronically diminishing trabecular function in both eyes. A finite portion of the trabecular meshwork in eyes with angle recession is initially rendered dysfunctional by the injury and/or the healing process. With time, the outflow capacity of the remaining meshwork is gradually reduced because of preexisting innate factors; the ultimate result is elevated IOP.

Fifth, chronic elevation of IOP leads to optic neuropathy characterized by progressive optic cupping and visual field loss.

Frequency

United States

The reported frequency of angle recession as a complication of blunt trauma is 20-94%. Several reports have described incidences of angle recession in more than 75% of bluntly injured eyes. Angle recession after traumatic hyphema occurs in 71-100% of cases.

Of eyes with identifiable angle recession, 0-20% will develop glaucoma. The onset of glaucoma is extremely variable, ranging from immediately after trauma to months or even many years later. Two peak incidences have been suggested to represent the early and late onset of angle-recession glaucoma; this observation may indicate separate pathologic mechanisms. The underlying differences are not well understood. The risk of eventual progression to glaucoma is generally thought to be proportionate to the extent of the angle recession, though the presence of angle recession alone is not a good predictor of glaucoma.

Glaucoma after angle recession of less than 180° is unusual; recessions greater than 180° are associated with a 4-9% incidence of glaucoma. Eyes with angle recession of greater than 240° appear to be at the highest risk of chronic glaucoma.

More than 1 million Americans have ocular injuries each year. A 1988 population-based study of adults in New England yielded an annual rate of 9.75 eye injuries per 1000 population based on self-reported histories. In 1990, the estimated hospitalization rate with ocular trauma was 15.2 cases per 100,000 children per year.

Work-related injuries have been reported as 13-18% of all cases of eye trauma. Injuries at home account for 27-31%, followed by assault (11-37%), recreation (about 25%), travel (about 5%), and miscellaneous causes (eg, injuries at school, unknown causes; <5%). Rates of bilateral injuries are as high as 27%.

The incidence of angle recession in the United States is not reported, but it has been described in 20-94% of eyes affected by blunt trauma. A 1987 study involving the routine examination of asymptomatic boxers found angle recession in 19%, with 8% having bilateral angle recession. Blunt eye injuries are estimated to account for more than 60% of all episodes of eye trauma. Angle recession is one of the most common complications after ocular contusion. Angle recession is observed in 71-100% of cases of traumatic hyphema. By contrast, angle-recession glaucoma occurs relatively infrequently. Of those eyes with known angle recession, 0-20% subsequently develops glaucoma.

International

Specific epidemiologic data regarding angle recession in other countries is scarce. Limited, worldwide epidemiologic data regarding eye trauma are similar to findings in the United States; however, differences exist in the high-risk activities leading to eye trauma, especially when rural and urban populations are compared. Most reports verify that contusional injuries represent most cases of eye trauma, but rates of angle recession or traumatic glaucoma are not well documented.

A study of Australian adults older than 40 years yielded a lifetime cumulative rate of eye injury of 21.1%. Among men, the rural rate was 42.1% compared with 30.5% for urban men. Workplace injuries predominated at 60%, with home injuries closer to agreement with the U.S. figure of 24%.

Results of 1995 study of ocular trauma in the Nigerian population were in agreement regarding the rate of home injuries, revealing a rate of 26.4%. This study showed that women and children at the greater risk of sustaining eye trauma during domestic activities.

The 1988 Israeli Ocular Injuries Study showed that injuries occurring at home were the most frequent type of eye trauma in Israel. A 1996 report described a predominance of home injuries in Scotland.

A 1994 population-based survey was based on gonioscopy in individuals older than 40 years in a community in South Africa. The authors reported a cumulative prevalence of angle recession of 14.6%. Among eyes with 360° of angle recession, 8% had glaucoma, and the overall prevalence of glaucoma of eyes with any degree of angle recession was 5.5%.

Mortality/Morbidity

Ocular injury is a relatively common comorbidity in patients admitted with major head trauma.

  • A study in 1999 revealed ocular injuries in 55% of all patients with facial injuries and in 16% of those with major trauma.
  • Mortality in association with serious ocular trauma is related to non-ophthalmic complications of the underlying trauma, though specific rates have not been reported.
  • Estimating the public magnitude of visual disability resulting from traumatic glaucoma is difficult because of its chronic nature and the lack of reported outcomes. Published reports of visual outcomes after eye trauma usually describe short-term results.
  • A 1996 epidemiologic study showed that the annual cumulative incidence of serious ocular trauma necessitating hospital admission is approximately 8 cases per 100,000 population. Of those cases, approximately 13% of patients had a poor visual outcome, and 10.7% had blindness as an outcome.
  • Angle-recession glaucoma can have onset years after the original episode of trauma. The long-term incidence of substantial vision loss or blindness due to posttraumatic glaucoma has not been reported.

Race

No known racial predilection exists.

  • Because of the possible relationship of POAG with angle-recession glaucoma, it can be theorized that African Americans may be at an increased risk of glaucoma after contusional eye trauma.
  • In addition, 1 urban study reported in 1991 showed that, at an inner city hospital in Los Angeles, African American patients had eye injuries more than twice as frequently as Hispanic patients.
  • A comparison of the rates of progression to angle-recession glaucoma among different races has not yet been reported.

Sex

No sex predilection for angle-recession glaucoma has been reported.

  • A strong predominance of eye trauma exists in men, who usually outnumber women by 4:1. Therefore, it may be assumed that angle recession and angle-recession glaucoma occur most frequently in men.
  • Among children, eye injuries occur more frequently in boys than girls.
  • Compared with men, women appear to be at greater risk of sustaining eye injuries at home.

Age

The age risk of angle recession has not been formally described.

  • Because of the potential for delayed or late onset after a blunt injury, angle-recession glaucoma is most likely diagnosed in mid or late adulthood. It may be misidentified as POAG because late angle abnormalities may be subtle on examination. A distant or even forgotten history of eye trauma may result in the condition being overlooked, especially in elderly persons.
  • In general, ocular trauma occurs most commonly during young adulthood. The annual incidence of pediatric eye injuries has been reported at 15 cases per 100,000 population. Angle-recession glaucoma has been described in childhood.
  • Among adults, the risk of injury appears to steeply decline with advancing age. Studies of urban populations have indicated that elderly persons have only 1.6% of all eye traumas, and for persons older than 65 years, eye injuries are most often the result of a fall.



History

Although nonpenetrating eye trauma invariably precedes angle recession, the patient may forget details of the injury or the entire episode after a number of years have passed. In addition, patients with angle-recession glaucoma, like patients with other forms of glaucoma, may present with no specific eye or visual complaints.

  • A unilateral cataract in a young or middle-aged adult should raise the suspicion of remote trauma, even when the history is negative.
  • In cases of suspected traumatic angle recession, careful history taking may elicit otherwise forgotten information.
  • In elderly patients, rule out a history of falls.
  • Some patients do not report any history of trauma despite extensive questioning. Lack of a positive history does not rule out angle recession.

Physical

Unilateral elevation of IOP is a hallmark finding in angle-recession glaucoma, but it may not be noted in early stages of the disorder.

  • Ideally, angle recession should be discovered before glaucoma develops so that the risk of glaucoma can be assessed and follow-up care arranged accordingly.
  • High IOPs noted early after injury (within the first few months of injury) may indicate extensive trabecular damage and a poor prognosis.
  • Angle recession is always diagnosed by means of gonioscopy.
    • The clinical appearance of the affected angle varies with the depth of the tear in the ciliary body and with the amount of time passed after the injury.
    • Typically, an irregularly wide ciliary body band is visible with retroplacement of the iris root. The angle appears abnormally deep in the involved areas. This characteristic appearance is due to a cleavage between the longitudinal and circular muscles of the ciliary body. After years of healing, the fissure may no longer be visible. In fact, when many years have passed after the contusional injury, angle recession may be difficult to recognize.
  • Comparison with the angles in the injured and uninjured eyes is important, particularly in cases with subtle findings. Documented asymmetry supports the diagnosis.
  • Angle recession should be differentiated from cyclodialysis, which is the disinsertion of the ciliary body from its attachment to the scleral spur.
  • A number of anterior segment abnormalities often accompany angle recession:
    • Cyclodialysis
    • Iridodialysis
    • Iridoschisis
    • Anterior synechia
    • Iris sphincter tears
    • Mydriasis
    • Iris atrophy
    • Transillumination defects
    • Iritis
    • Zonular breaks
    • Phacodonesis
    • Subluxated lens
    • Cataract
  • A strong association exists between hyphema and angle recession, but the ciliary body also can be severely damaged from blunt trauma, without the appearance of a hyphema.
  • Posterior segment abnormalities, which may signify prior episodes of trauma, include the following:
    • Vitreous opacities
    • Chorioretinal scars
    • Macular hole
    • Retinal breaks
    • Retinal detachment
    • Optic atrophy
  • An uncontrolled and sustained elevation in IOP in angle-recession glaucoma, as in other forms of glaucoma, ultimately leads to progressive cupping of the optic nerve and loss of the visual field.
  • Snellen visual acuity is typically uninvolved until the late stages of glaucoma.
  • Formal visual field testing is of paramount importance in diagnosing and monitoring the disorder.

Causes

Any cause of nonpenetrating ocular trauma can result in angle-recession glaucoma. The episode may be seemingly trivial and forgotten. The circumstances of the injury can be variable, often involving trauma from high-velocity blunt objects or projectiles (eg, stones, balls, champagne stoppers, bungee cords, toys, tree branches, fruit, airbags, fists). Ocular surgery, such as penetrating keratoplasty or cataract extraction may also result in angle recession.

The most common types of blunt trauma are the following:

  • Sports injuries (eg, boxing, paintball, airsoft gun toys)
  • Motor vehicle accidents (eg, airbag deployment, other facial trauma)
  • Assaults
  • Falls
  • Military combat injuries
  • Accidents (eg, industrial, farm, home, bungee cord injuries)
  • Other (eg, school accidents, natural disasters)



Glaucoma, Angle Closure, Acute
Glaucoma, Angle Closure, Chronic
Glaucoma, Lens-Particle
Glaucoma, Neovascular
Glaucoma, Phacolytic
Glaucoma, Pigmentary
Glaucoma, Primary Open Angle
Glaucoma, Pseudoexfoliation
Glaucoma, Unilateral
Glaucoma, Uveitic
Melanoma, Ciliary Body
Melanoma, Iris

Other Problems to be Considered

Elevated episcleral venous pressure/carotid cavernous fistula
Iridocorneal endothelial (ICE) syndrome
Uveitis-glaucoma-hyphema (UGH) syndrome

Angle recession refers to a tear between the circular and longitudinal fibers of the ciliary body. Cyclodialysis is defined as a detachment of the ciliary body from its insertion at the scleral spur. Iridodialysis is separation of the iris root from its attachment to the anterior ciliary body. By comparison, iridoschisis refers to splitting of layers of iris stroma. All of these conditions are sequelae of blunt ocular trauma, and any of these conditions may coexist.



Imaging Studies

  • The diagnosis of angle recession is confirmed during office examination.
  • Usually, imaging is necessary only to evaluate comorbidities due to trauma.
    • Occasionally, CT scanning of the orbits is needed to evaluate for orbital fractures or foreign bodies.
    • Emergency neuroimaging if typically indicated after major head trauma.
  • On occasion, gonioscopy is difficult or impossible in traumatized eyes because of corneal edema, corneal scarring, hyphema, synechia, or other opacity. In such cases, high-frequency ultrasound biomicroscopy (as a supplemental tool to standard office examination) is effective for evaluating abnormalities of the angle in the anterior chamber.
    • Ultrasound biomicroscopy produces high-resolution axial images of the anterior globe, providing cross-sectional views of the angle in vivo similar to those of a histologic section.
    • This noninvasive procedure is readily performed in a clinical setting in an intact globe, and it provides information otherwise unavailable from convention examination.
    • High-resolution images of angle recession, iridodialysis, and cyclodialysis have been described. When available, high-frequency ultrasound biomicroscopy is a useful diagnostic adjunct in evaluating trauma to the anterior segment and other ocular disease.

Other Tests

  • Because progressive loss of visual field is a potential outcome, formal visual field testing is the most important adjunctive diagnostic modality in detecting and following up the disorder.
  • Several authors have described the use of tonography to evaluate patients with traumatic angle recession.
    • Loss of outflow facility, as measured on tonographic studies, is common after angle-recession injuries, and this finding is statistically significant in cases of angle recession as a group.
    • However, role of tonography in predicting the risk of glaucoma appears to be of little value in any single case.
    • Tonography might not be available to the average practitioner, and it is currently an unnecessary adjunct to the evaluation and management of angle recession.
  • Optic nerve photography is also important for documenting and monitoring glaucoma.
  • Computerized disk analysis and analysis of nerve-fiber layers has been gaining acceptance in the diagnosis and management of all forms of glaucoma.

Procedures

  • Gonioscopy is the only clinical procedure that must be performed before angle recession can be diagnosed.
    • Use of a 1- or 3-mirror Goldman goniolens, which provides the greatest magnification of angle structures, is recommended.
    • Use of the Koeppe lens for examining and photographing the anterior chamber angle is also advocated. Use of Koeppe lenses allows for easy comparison with the uninjured eye because they can be placed simultaneously on the eyes.
    • The Posner 4-mirror gonioprism is not preferred for evaluating suspected angle recession because of the potential for indenting the central cornea, inducing artificial deepening, and/or distorting of the anterior-chamber angle.

Histologic Findings

Histopathologic findings of eyes with angle-recession deformities have been well described and include features of both light microscopy and electron microscopy (EM).

In their classic report in 1962, Wolf and Zimmerman described a characteristic tear extending into the anterior ciliary body, separating the longitudinal and circular fibers.

  • The extent of dissection varied, but the longitudinal muscle remained attached to the scleral spur.
  • Retroplacement of the iris root and ciliary processes was noted microscopically. An association with other abnormal findings, including iridodialysis, rupture of the trabecular meshwork, or cyclodialysis, was documented. Late findings were also reported.
  • Over time, healing of the ciliary body laceration was noted. This was accompanied by atrophy of the circular muscle at involved sites, resulting in a fusiform contour of the ciliary body, as seen on axial sections.
  • Other histopathologic findings in late cases provided clues to the mechanism of glaucoma in angle recession. Marked degeneration of the trabecular meshwork was prominent.
  • In some cases, an abnormal hyaline membrane, continuous with the Descemet membrane, was formed over the inner surface of the trabecular meshwork, sometimes extending further onto the anterior iris surface. Abnormal corneal endothelial proliferation may occur in some eyes with traumatic angle deformities. The histologic observations showed proliferation of the endothelium posterior to the Schwalbe ring with secretion of a Descemet-like membrane covering the meshwork and perhaps reducing trabecular outflow capacity of the involved angle.

    EM of some eyes with angle recession may verify the presence of a hyaline membrane over the inner trabecular region, with an endothelial layer structurally similar to that of normal corneal endothelium. Other EM findings include loss of intertrabecular spaces and a decrease or absence of the trabecular endothelial cells. Thickening of the juxtacanicular connective tissue has been observed, with loss of vacuole lining within the endothelial cells lining the inner wall of the Schlemm canal.

Although the exact pathology of angle-recession glaucoma is not fully established, the ultrastructural abnormalities described above support a chronic progressive mechanism of trabecular outflow dysfunction, leading to pressure elevation over time.



Medical Care

The necessity of initiating treatment of angle-recession glaucoma depends on the severity of the initial injury and the somewhat variable clinical course as healing progresses. Normotensive eyes with angle recession of more than 180° should be routinely reexamined for an indefinite period to monitor for the development of late glaucoma.

  • In patients with an abnormal elevation of IOP, the decision to begin therapy is based on the clinician's overall assessment of the risk of vision loss.
    • The severity of IOP elevation, optic nerve appearance, and visual field findings contribute to the decision-making process.
    • Treatment almost always is indicated when the IOP is greater than an arbitrary range of 25-28 mm Hg and/or when glaucomatous optic nerve or visual field changes are documented over time.
  • After the diagnosis of angle recession is established, its management is similar to that of POAG, with a few special considerations.
    • Use of topical aqueous suppressants in the initial medical treatment is preferred; these include beta-antagonists, alpha-agonists, and carbonic anhydrase inhibitors.
    • Prostaglandin analogs, which increase uveoscleral outflow, have a theoretical benefit in angle recession because the trabecular meshwork is thought to be dysfunctional in such cases.
    • Use caution in administering miotic agents, because pilocarpine has been reported to cause a paradoxical elevation of IOP in angle recession, presumably due to a reduction of uveoscleral outflow.
    • Atropine has been reported to reduce IOP in angle-recession glaucoma; therefore, cycloplegic agents may have a role in treatment.
    • A trial of a cycloplegic agent should be reserved either for cases involving failure of conventional glaucoma therapy or for cases with other indications for cycloplegia (eg, inflammation).
  • The response to medical therapy in angle-recession glaucoma is variable.
    • Topical medical treatment may be effective in cases of mild-to-moderate angle recession, while elevated IOP of eyes with extensive angle injury eventually may become refractory to medications.
    • Severe early cases may fail to show an initial response to aggressive medical treatment, indicating a poorer overall prognosis.

Surgical Care

Surgical intervention in angle-recession glaucoma is usually indicated when maximally tolerated medical treatment has failed and when the risk of progressive visual loss outweighs the estimated risk of the planned surgical management. In general, outcomes of surgical treatment are less favorable than those of POAG.

  • Argon laser trabeculoplasty
    • Argon laser trabeculoplasty (ALT) has been associated with short-term success, though the procedure has been reported to have poor long-term effectiveness, particularly in eyes with more than 180° of angle recession.
    • IOP elevation may become worse in response to ALT.
    • In eyes with less than 180° of angle recession, ALT may be beneficial if applied to only the trabecular meshwork of the nonrecessed portions of the anterior-chamber angle.
  • Alternative laser procedures
    • Nd:YAG laser trabeculopuncture (YLT) has been used with variable success. A 1992 study demonstrated a 100% failure rate in eyes with 360° angle recession.
    • Currently, YLT is not recommended for the routine management of angle-recession glaucoma.
    • Other laser procedures that have shown promise are transscleral krypton laser cyclophotocoagulation, transpupillary argon laser cyclophotocoagulation, and endoscopic cyclophotocoagulation.
  • Filtration surgery
    • Filtration surgery has a success rate lower than that of POAG.
    • Trabeculectomy in eyes with angle recession is associated with decreased postoperative reduction in IOP, increased rates of bleb fibrosis and bleb failure, and increased dependence on postoperative medical treatment of glaucoma.
    • The adjunctive use of antimetabolites, particularly mitomycin C, can improve the success of trabeculectomy. This finding suggests that an antimetabolite should be used during the initial filtering procedure. A 2001 report described effective results with an acceptable complication rate in such cases.
  • Tube shunt devices
    • Benefits with the implantation of tube shunt devices have been demonstrated, but outcomes are reportedly less successful in angle recession than in other types of refractory glaucoma.
    • A 1993 study showed the superior results of trabeculectomy with antimetabolite over Molteno implantation in cases of posttraumatic angle-recession glaucoma.

Consultations

  • Consultation with a glaucoma specialist should be considered in cases with an uncertain diagnosis, with early severe IOP elevation, with a poor response to treatment, or with advanced visual field loss.
  • Depending on the presence of other posttraumatic ocular or orbital abnormalities, consider referring the patient to subspecialists in corneal and/or external disease, oculoplastics retinal disease, or neuro-ophthalmology.



The preferred drugs have the pharmacologic action of aqueous suppression. A beta-antagonist is the common first choice, with subsequent additions of an alpha-agonist and/or a carbonic anhydrase inhibitor, as necessary. Prostaglandin analogs probably have a useful role, but the use of miotic agents is controversial and not routinely recommended.

The goal of therapy is IOP reduction. Medications often must be used long term. IOP should be monitored whenever medications are discontinued or changed, and therapy should be restarted, if necessary.

Drug Category: Beta-agonists

Topical beta-adrenergic receptor antagonists decrease the production of aqueous humor by the ciliary body. Adverse effects are due to systemic absorption of the drug, which causes decreased cardiac output and bronchoconstriction. These agents may cause bronchospasm, bradycardia, heart block, or hypotension. Monitor the patient's pulse rate and blood pressure. Patients may be instructed to perform punctal occlusion after administering the drops. Some patients may have depression or anxiety, and sexual dysfunction may occur or worsen.

Drug NameTimolol maleate (Timoptic, Timoptic XE) 0.25%, 0.5%
DescriptionMay reduce elevated or normal IOP, with or without glaucoma, by reducing aqueous humor production.
Adult DoseTimoptic: 1 gtt in affected eye bid
Timoptic XE: 1 gtt in affected eye qd
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; bronchial asthma; sinus bradycardia; second- and third-degree AV block; severe COPD; overt cardiac failure; cardiogenic shock
InteractionsMay cause bradycardia and asystole in combination with systemic beta-blockers (may cause additive effects)
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsMay contain sulfites, which can cause allergic-type reactions in susceptible patients

Drug NameLevobunolol (Betagan, AKBeta) 0.25%, 0.5%
DescriptionNonselective beta-adrenergic blocking agent. Lowers IOP by reducing aqueous humor production.
Adult Dose1 gtt in affected eye bid
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; bronchial asthma; severe COPD; sinus bradycardia; second- and third-degree AV block; overt cardiac failure; cardiogenic shock
InteractionsMay cause bradycardia and asystole in combination with systemic beta-blockers (may cause additive effects)
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsMay contain sulfites, which may cause allergic-type reactions in certain susceptible persons

Drug NameCarteolol HCl (Ocupress) 1%
DescriptionBlocks beta1- and beta2-receptors. Has mild intrinsic sympathomimetic effects.
Adult Dose1 gtt in affected eye bid
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; congestive heart failure; asthma; cardiac conduction defects; breastfeeding
InteractionsMay cause bradycardia and asystole in combination with systemic beta-blockers (may cause additive effects)
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsMay contain sulfites, which may cause allergic-type reactions in certain susceptible persons

Drug NameBetaxolol (Betoptic) 0.25%, 0.5%
DescriptionSelectively blocks beta1-adrenergic receptors. Reduces IOP by reducing aqueous humor production.
Adult Dose1-2 gtt in affected eye(s) bid; consider concomitant therapy if IOP not at satisfactory level
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; bronchial asthma; severe COPD; sinus bradycardia; second- and third-degree AV block; overt cardiac failure; cardiogenic shock
InteractionsMay have additive systemic effects if patient already taking systemic beta-blockers
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsBeta-blockade may potentiate muscle weakness consistent with myasthenic symptoms; may contain sulfites, which may cause hypersensitivity reactions in susceptible persons

Drug Category: Adrenergic agonists

Topical adrenergic agonists (sympathomimetics) decrease aqueous production and reduce resistance to aqueous outflow. Adverse effects include dry mouth and hypersensitivity.

Drug NameApraclonidine (Iopidine) 0.5%, 1%
DescriptionSelective alpha-adrenergic agonist that suppresses aqueous production. Minimal cardiovascular effect.
Adult Dose1-2 gtt in affected eye tid
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; current use of MAOIs or use in past 14 d
InteractionsCoadministration with beta-blockers may further decrease IOP; frequently monitor pulse and BP when giving cardiovascular drugs; not for concurrent use with MAOIs
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCaution in coronary insufficiency, chronic renal failure, recent MI, cerebrovascular disease, Raynaud disease, thromboangiitis obliterans, and depression

Drug NameBrimonidine (Alphagan)
DescriptionSelective alpha2-receptor agonist. Reduces aqueous humor formation. Possibly increases uveoscleral outflow.
Adult Dose1 gtt in affected eye tid; bid dosing may be as effective
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; patients receiving MAOIs
InteractionsCoadministration with topical beta-blockers may further decrease IOP; tricyclic antidepressants may decrease effects; CNS depressants (eg, barbiturates, opiates, sedatives) may potentiate effects
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsCaution in cardiovascular disease, depression, cerebral or coronary insufficiency, orthostatic hypotension, and Raynaud syndrome

Drug Category: Carbonic anhydrase inhibitors

These drugs reduce secretion of the aqueous humor by inhibiting carbonic anhydrase in the ciliary body. These agents are less effective than many other classes of drugs and have a shorter duration of action. Adverse effects are relatively rare but include superficial punctate keratitis, acidosis, paresthesias, nausea, depression, and lassitude. Corneal decompensation has been reported when this class of drugs is used in patients with corneal endothelial dysfunction.

Drug NameDorzolamide HCl (Trusopt) 2%
DescriptionUsed concomitantly with other topical ophthalmic drugs to lower IOP. If > 1 ophthalmic drug used, administer >10 min apart. Reversibly inhibits carbonic anhydrase, reducing hydrogen ion secretion at renal tubule. Increases renal excretion of sodium, potassium bicarbonate, and water to decrease aqueous humor production.
Adult Dose1 gtt in affected eye(s) tid
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsCoadministration with high-dose salicylate therapy may increase toxicity; may have additive systemic effects if patient already taking oral carbonic anhydrase inhibitors
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsMay cause ocular discomfort, superficial punctate keratitis; to minimize adverse effects, may start qd or bid and gradually advance to tid

Drug NameBrinzolamide (Azopt) 1%
DescriptionCatalyzes reversible reaction involving hydration of carbon dioxide and dehydration of carbonic acid. May use concomitantly with other topical ophthalmic drug products to lower IOP. If > 1 topical ophthalmic drug used, administer >10 min apart.
Adult Dose1 gtt in affected eye tid
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsMay have additive systemic effects if patient is already taking oral carbonic anhydrase inhibitors
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsLocal ocular adverse effects, primarily conjunctivitis and lid reactions, possible with long-term dorzolamide (discontinue and evaluate patient before restarting)

Drug NameDorzolamide HCl/timolol maleate (Cosopt)
DescriptionDorzolamide is carbonic anhydrase inhibitor that may decrease aqueous humor secretion, decreasing IOP; presumably slows bicarbonate ion formation with subsequent reduction in sodium and fluid transport. Timolol is nonselective beta-adrenergic receptor blocker; decreases IOP by decreasing aqueous humor secretion. Administered together bid may reduce IOP more than either alone, but reduction not as much as that with concomitant dorzolamide tid and timolol bid.
Adult Dose1 gtt in affected eye bid
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsCoadministration with high-dose salicylate may increase toxicity; may have additive systemic effects if patient already taking oral carbonic anhydrase inhibitors
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsLocal ocular adverse effects, primarily conjunctivitis and lid reactions, possible with long-term dorzolamide (discontinue and evaluate patient before restarting); may contain sulfites, which may cause allergic-type reactions in susceptible patients

Drug NameAcetazolamide (Diamox, Diamox Sequels)
DescriptionReduces aqueous humor formation by inhibiting enzyme carbonic anhydrase, decreasing IOP.
Adult Dose125-250 mg tab PO qid
Diamox Sequels: 500 mg cap PO bid; not to exceed 1 g/d
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; hepatic disease; severe renal disease; adrenocortical insufficiency; severe pulmonary obstruction
InteractionsCan decrease therapeutic levels of lithium and alter drug (amphetamine, quinidine, phenobarbital, salicylate) excretion by alkalinizing urine
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsComa in impaired renal function; may substantially increase blood glucose level in some diabetic patients; may cause hypokalemia and bone marrow suppression

Drug NameMethazolamide (Neptazane, GlaucTabs)
DescriptionReduces aqueous humor formation by inhibiting carbonic anhydrase, decreasing IOP.
Adult Dose50-100 mg PO bid
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; marked renal or hepatic dysfunction; cirrhosis; serum electrolyte disorders; pregnancy (teratogenic in animal studies)
InteractionsMay increase salicylate and digoxin toxicity; coadministration with diuretics or corticosteroids may induce hypokalemia; decreases effects of lithium and alters excretion of other drugs by alkalinizing urine
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCaution in respiratory acidosis and diabetes mellitus; impairs mental alertness and/or physical coordination; hematuria, glycosuria, polyuria, hepatic insufficiency, bone marrow suppression, thrombocytopenia/purpura, agranulocytosis, urticaria, pruritus, and rash may occur

Drug Category: Prostaglandin analogs

These selective agonists act on prostaglandin receptors in the eye to lower IOP by increasing uveoscleral outflow.

Drug NameLatanoprost (Xalatan)
DescriptionDecreases IOP by increasing outflow of aqueous humor.
Adult Dose1 gtt in affected eye qhs
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; pregnancy; inflammatory glaucoma; neovascular glaucoma
InteractionsCoadministration with eye drops containing thimerosal (preservative) may reduce effects (give at 5-min intervals)
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCaution if history of aphakia, keratitis, uveitis, cystoid macular edema (CME), or pseudophakia with other risk factors for CME; do not administer while patient wearing contact lenses; may increase brown pigment in iris, and may gradually change eye color (unknown physiologic effect)

Drug NameBimatoprost ophthalmic solution (Lumigan)
DescriptionProstamide analog with ocular hypotensive activity. Mimics IOP-lowering activity via the prostamide pathway. Used to reduce IOP in open-angle glaucoma or ocular hypertension.
Adult Dose1 gtt 0.03% solution in affected eye(s) hs; not to exceed 1 dose/d
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsMay permanently increase pigment in iris (increases brown pigment) and eyelid; may increase eyelash growth; may cause bacterial keratitis; caution in uveitis or macular edema; do not instill if patient wearing contact lenses

Drug NameTravoprost ophthalmic solution (Travatan)
DescriptionProstaglandin F2-alpha analog. Selective prostaglandin F2 receptors prostanoid receptor agonist; may reduce IOP by increasing uveoscleral outflow. Used to treat open-angle glaucoma or ocular hypertension.
Adult Dose1 gtt in affected eye(s) hs; not to exceed 1 dose/d
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; pregnancy
InteractionsNone reported
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsOcular hyperemia common; may permanently increase pigment in iris (increases brown pigment) and eyelid; may increase eyelash growth; may cause bacterial keratitis; caution in uveitis or macular edema; do not instill if patient wearing contact lenses

Drug NameUnoprostone ophthalmic (Rescula)
DescriptionProstaglandin F2-alpha analog. Selective FP prostanoid receptor agonist; may reduce IOP by increasing uveoscleral outflow. Used to treat open-angle glaucoma or ocular hypertension.
Adult Dose1 gtt in affected eye(s) bid
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity
InteractionsNone reported
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsOcular hyperemia common; may permanently increase pigment in iris (increases brown pigment) and eyelid; may increase eyelash growth; may cause bacterial keratitis; caution in uveitis or macular edema; do not instill if patient wearing contact lenses



Further Outpatient Care

  • As in other types of glaucoma, follow-up depends on the degree of IOP control and the risk of progressive loss of the visual field.
  • Patients with an early increase in IOP after blunt trauma should be reexamined every 4-6 weeks during the first year to monitor their condition.
    • Some early cases are self-limited, but patients should still be observed after their condition appears to resolve.
    • Other early cases represent a severe form of the disease that may be refractory to standard medical treatment; such cases warrant more frequent follow-up.
  • In cases of angle recession of greater than 180° that initially have no evidence of glaucoma, late-onset glaucoma can potentially occur, even many years after the injury. Annual examinations should be performed for an indefinite period.

In/Out Patient Meds

Deterrence/Prevention

  • The incidence of angle-recession glaucoma can be reduced by preventing the underlying trauma.
  • Data indicate that most pediatric and adult eye injuries (eg, sports-related accidents) are preventable.
  • Public education on the use of eye, face, or head protection during high-risk activities may lower the incidence of ocular injuries.
  • Public safety standards to reduce rates of eye injury can be achieved by enacting legislative policies such as seatbelt or helmet laws.

Complications

  • Nonglaucomatous comorbidity in eyes with angle recession increases the risk of vision loss. Traumatic insults to the cornea, iris, lens, vitreous, retina, or optic nerve may contribute to vision-threatening sequelae.
  • Traumatic cataract often accompanies angle recession.
    • Gonioscopy should always be performed when a patient with a unilateral cataract is evaluated, even when his or her history is negative for trauma.
    • After surgical management, the risk of complications is higher with a traumatic cataract than with a senile cataract.
  • Intraoperative complications include the following:
    • Zonular dialysis
    • Vitreous loss
    • Intraocular hemorrhage
    • Inadequate posterior intraocular lens (IOL) support: Zonular injury is a common finding in such cases. When zonular defects are small, placement of the IOL into the capsular bag usually can be achieved without further complication. Placement of an anterior-chamber IOL is not preferred in eyes with even minimal angle recession, and it is fully contraindicated when the angle is recessed more than 180°.
  • Postoperative complications
    • IOP elevation
    • Inflammation
    • IOL malposition
    • Pupil capture
    • Intraocular hemorrhage
    • Glare
    • Monocular diplopia: Symptoms may result from iris abnormalities.
  • Cataract extraction in eyes with known angle-recession deformities should be approached with caution.
  • The most common posterior-segment complications after blunt trauma include macular lesions and peripheral retinal tears.
    • Posttraumatic entities involving the macula include the following:
      • Macular cysts
      • Macular holes
      • Hyperplastic-atrophic pigment epitheliopathy
      • Choroidal rupture: This is another possible finding in traumatized eyes and sometimes leads to secondary neovascular degeneration or disciform scarring.
    • Traumatic abnormalities of the peripheral retina include the following:
      • Atrophic holes
      • Horseshoe tears
      • Operculated tears
      • Retinal dialysis
      • Retinal detachment

Prognosis

  • No formal data indicate the long-term visual outcomes of eyes with chronic angle-recession glaucoma. Eyes that develop early-onset angle-recession glaucoma are thought to represent a subgroup with most extensive angle injury, but the visible degree of angle recession is not correlated with the severity of glaucoma in this group.
  • Late-onset angle-recession glaucoma almost always occurs in eyes with greater than 180° of angle recession, and the risk appears to increase with the extent of angle recession. Eyes with a 360° angle recession are at greatest risk.
  • As in most types of glaucoma, angle-recession glaucoma can cause progressive visual field loss and blindness.
    • The risk of visual loss depends on many factors, particularly the timeliness of initial diagnosis and the course of management.
    • Response of elevated IOP to medical therapy varies, and with time, IOP control may deteriorate despite dependence on multiple medications.
    • Favorable results have been reported for surgical intervention of angle-recession glaucoma, but success rates are lower than those of other forms of glaucoma.

Patient Education



Medical/Legal Pitfalls

  • Medicolegal concerns may arise from an allegation of a failure to diagnose the disorder or from delays in providing appropriate care.
    • Angle recession should be suspected in any patient with a unilateral cataract or with a history of eye injury, even if the traumatic event seems trivial.
    • Gonioscopy should be routinely performed in the evaluation of a patient with a history—even a remote history—of blunt trauma, particularly after a hyphema resolves.
    • Gonioscopy should be performed in all patients with suspected POAG.
    • Angles should be examined in patients with asymmetric IOPs, unilateral cataract, zonular weakness, iridodialysis, or other abnormalities of the anterior segment.
  • Failure to recommend appropriate follow-up care is a pitfall.
    • Patients with greater than 180° of angle recession should receive lifelong follow-up care, usually on an annual basis, to monitor for the development of glaucoma.
    • Patients should not be discharged from clinic because the onset of glaucoma may be many years after the injury.
  • Suboptimal monitoring of the relative effectiveness of the treatment provided is another pitfall.
    • Angle-recession glaucoma responds to both medical and surgical interventions somewhat unpredictably and with less favorable results than those of other types of glaucoma.
    • Adjustments to therapy or proceeding to more aggressive treatment measures may need to be accelerated in eyes with recalcitrant glaucoma.
    • Progression of visual field loss during a period with few or no changes in patient care may lead to medicolegal complaints or claims of an inappropriate treatment delay.

Special Concerns

  • Sickle cell anemia or trait is a systemic disorder that has multiple links to eye disease; therefore, it should be considered during the evaluation and treatment of patients with hyphema in the immediate period after blunt trauma.
  • Sickle cell anemia is a concern during the long-term management of eyes that develop angle-recession glaucoma because of the increased tendency for microvascular occlusions.
  • In general, patients with sickle cell anemia require more aggressive IOP control with glaucoma treatment than other patients because their eyes have a decreased tolerance of even moderate elevations in IOP.
  • In addition, carbonic anhydrase inhibitors and hyperosmotic agents are contraindicated in patients with sickle cell disease because of the effects of acidosis and diuresis.



Media file 1:  Irregular widening of the visible ciliary body in a quadrant with angle recession.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 2:  Angle recession. Note the marked posterior displacement of the iris, with a wide ciliary body band posterior to the scleral spur.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 3:  Gonioscopic examination many years after blunt trauma in a patient with angle-recession glaucoma. Note the irregular contour of the iris, with loss of detail of angle structures. Classic findings of angle recession may become subtle or be obscured over time.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo



  • Berinstein DM, Gentile RC, Sidoti PA. Ultrasound biomicroscopy in anterior ocular trauma. Ophthalmic Surg Lasers. Mar 1997;28(3):201-7. [Medline].
  • Canavan YM, Archer DB. Anterior segment consequences of blunt ocular injury. Br J Ophthalmol. Sep 1982;66(9):549-55. [Medline].
  • Chorich LJ 3rd, Davidorf FH, Chambers RB. Bungee cord-associated ocular injuries. Am J Ophth. 1998;125(2):270-2. [Medline].
  • Endo S, Ishida N, Yamaguchi T. Tear in the trabecular meshwork caused by an airsoft gun. Am J Ophth. 2001;131(5):656-7. [Medline].
  • Fineman MS, Fischer DH, Jeffers JB. Changing trends in paintball sport-related ocular injuries. Arch Ophthalmol. Jan 2000;118(1):60-4. [Medline].
  • Fukuchi T, Iwata K, Sawaguchi S. Nd:YAG laser trabeculopuncture (YLT) for glaucoma with traumatic angle recession. Graefes Arch Clin Exp Ophthalmol. Oct 1993;231(10):571-6. [Medline].
  • Glynn RJ, Seddon JM, Berlin BM. The incidence of eye injuries in New England adults. Arch Ophthalmol. Jun 1988;106(6):785-9. [Medline].
  • Iwamoto T, Witmer R, Landolt E. Light and electron microscopy in absolute glaucoma with pigment dispersion phenomena and contusion angle deformity. Am J Ophthalmol. Aug 1971;72(2):420-34. [Medline].
  • Manners T, Salmon JF, Barron A. Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma. Br J Ophth. 2001;85(2):159-63. [Medline].
  • McCarty CA, Fu CL, Taylor HR. Epidemiology of ocular trauma in Australia. Ophthalmology. Sep 1999;106(9):1847-52. [Medline].
  • Melamed S, Ashkenazi I, Gutman I. Nd:YAG laser trabeculopuncture in angle-recession glaucoma. Ophthalmic Surg. Jan 1992;23(1):31-5. [Medline].
  • Mermoud A, Salmon JF, Straker C. Post-traumatic angle recession glaucoma: a risk factor for bleb failure after trabeculectomy. Br J Ophthalmol. Oct 1993;77(10):631-4. [Medline].
  • Roller RA, Almond NB, Anderson W. Traumatic iridodialysis in a student naval aviator applicant. Aviat Space Environ Med. 2005;76(2):147-50. [Medline].
  • Rumelt S, Bersudsky V, Blum-Hareuveni T. Preexisting and postoperative glaucoma in repeated corneal transplantation. Cornea. 2003;22(2):189. [Medline].
  • Salmon JF, Mermoud A, Ivey A. The detection of post-traumatic angle recession by gonioscopy in a population-based glaucoma survey. Ophthalmology. Nov 1994;101(11):1844-50. [Medline].
  • Shields MB, ed. Glaucomas associated with ocular trauma. In: Textbook of Glaucoma. 4th ed. Baltimore:. Lippincott Williams & Williams;1988: 339-44.
  • Sihota R, Sood NN, Agarwal HC. Traumatic glaucoma. Acta Ophthalmol Scand. Jun 1995;73(3):252-4. [Medline].
  • Strahlman E, Elman M, Daub E. Causes of pediatric eye injuries. A population-based study. Arch Ophthalmol. Apr 1990;108(4):603-6. [Medline].
  • Tesluk GC, Spaeth GL. The occurrence of primary open-angle glaucoma in the fellow eye of patients with unilateral angle-cleavage glaucoma. Ophthalmology. Jul 1985;92(7):904-11. [Medline].
  • Wolff SM, Zimmerman LE. Chronic secondary glaucoma. Association with retrodisplacement of iris root and deepening of the anterior chamber angle secondary to contusion. Am J Ophthalmol. 1962;84:547-63.

Glaucoma, Angle Recession excerpt

Article Last Updated: Aug 16, 2006